Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc.) on July 30, 2009. The filing addresses corporate governance changes, specifically the departure of a director and the election of a new director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Departure: Kenneth E. Jones retired as a member of the Board of Directors on July 30, 2009.
- Director Election: Dean Hollis was elected as a new Class 2 Director on July 30, 2009.
- Compensation Grant: In connection with his election, Mr. Hollis received an option to purchase 10,000 shares of Common Stock (vesting monthly over three years) and 3,333 Restricted Stock Units (vesting fully on the third anniversary).
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It confirms that Mr. Hollis has no material interest in any transaction exceeding $120,000 since the beginning of the last fiscal year.
Investor Verification Checklist
- Verify the identity of the registrant (Landec Corporation) to ensure it matches the intended investment target.
- Confirm the vesting schedule and terms of the 10,000 stock options and 3,333 RSUs granted to the new director.
- Review the attached press release (Exhibit 99.1) for additional context on the board composition.